Health
NHS England spends £160m on new ‘Covid-friendly’ cancer drugs – The Guardian
Patients to be given treatments less likely to damage immune system and in some cases able to be taken at home
NHS England is spending £160m on new Covid-friendly cancer drugs that will be less likely to damage the immune system and, in some cases, can be taken at home so that patients do not have to visit hospital.
NHS England said 2,000 patients had already benefitted from a range of treatments approved for use as swaps for existing drugs. More will be available from this week, after a series of deals struck between the NHS and pharma companies, it said in a statement.
Some of these new options mean …
-
General8 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
Business16 hours agoBell Potter names the best ASX shares to buy in October
-
Noosa News14 hours agoPerth Royal Show vendors upset by price hikes, say crowds are down in 2025
-
General13 hours agoAustralia welcomes Gaza peace progress, hostage release